MOSCOW (MRC) -- Evonik is raising the prices for its isophorone diamine, offered under the brand name VESTAMIN IPD by 10% on a global basis, as per the company's press release.
Due to significant higher costs attributed to geographical supply and demand imbalances this unavoidable increase will come into effect from 1st November 2017. All existing contracts will be honored.
By maximizing its global manufacturing infrastructure, and providing its customers with superior quality and excellent service, the Crosslinkers Business Line will continue to help customers grow in their respective markets and regions.
As MRC informed previously, Evonik Resource Efficiency will invest in a capacity expansion of its performance foams business at its production site in Darmstadt, Germany. The investment will increase the output of the facility by about 20% as a first step. The Group will be adding production equipment to its operations complex that manufactures products marketed under the Rohacell brand. The expanded production capacity is expected to be operational by the second half of 2017.
Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms. Evonik is active in over 100 countries around the world.
MRC